Mike Braun actually said...
The Promising Pathway Act is a commonsense step to give the FDA the flexibility it needs to serve Americans with these most trying diseases.
Context
Mike Braun advocates for the Promising Pathway Act to enhance FDA flexibility for rare disease treatments.
10/25/2023